These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20814954)

  • 1. Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007.
    Wang Z; Bhattacharyya T
    J Bone Miner Res; 2011 Mar; 26(3):553-60. PubMed ID: 20814954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry.
    Lee YK; Ha YC; Park C; Yoo JJ; Shin CS; Koo KH
    Osteoporos Int; 2013 Feb; 24(2):707-11. PubMed ID: 22618268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.
    Wang Z; Ward MM; Chan L; Bhattacharyya T
    Osteoporos Int; 2014 Aug; 25(8):2109-16. PubMed ID: 24846316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996-2012: An Ecological Analysis.
    Jha S; Wang Z; Laucis N; Bhattacharyya T
    J Bone Miner Res; 2015 Dec; 30(12):2179-87. PubMed ID: 26018247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.
    Park-Wyllie LY; Mamdani MM; Juurlink DN; Hawker GA; Gunraj N; Austin PC; Whelan DB; Weiler PJ; Laupacis A
    JAMA; 2011 Feb; 305(8):783-9. PubMed ID: 21343577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hip and Subtrochanteric or Femoral Shaft Fractures after Bisphosphonate Use in Korean Women, Using Korean National Sample Cohort.
    Won SH; Ahn S; Ji E; Park JW; Kim JK; Lee YK
    J Korean Med Sci; 2020 Jun; 35(25):e193. PubMed ID: 32597040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of proximal femoral fractures in South Korea.
    Yoon BH; Lee YK; Kim SC; Kim SH; Ha YC; Koo KH
    Arch Osteoporos; 2013; 8():157. PubMed ID: 24150727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates and hip and nontraumatic subtrochanteric femoral fractures in the Veterans Health Administration.
    Safford MM; Barasch A; Curtis JR; Outman R; Saag K
    J Clin Rheumatol; 2014 Oct; 20(7):357-62. PubMed ID: 25275761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in hospital care for hip fractures.
    Gehlbach SH; Avrunin JS; Puleo E
    Osteoporos Int; 2007 May; 18(5):585-91. PubMed ID: 17146592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical subtrochanteric fractures in Korean hip fracture study.
    Lee YK; Kim TY; Ha YC; Song SH; Kim JW; Shon HC; Chang JS; Koo KH
    Osteoporos Int; 2017 Oct; 28(10):2853-2858. PubMed ID: 28612307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtrochanteric fractures in bisphosphonate-naive patients: results from the HORIZON-recurrent fracture trial.
    Adachi JD; Lyles K; Boonen S; Colón-Emeric C; Hyldstrup L; Nordsletten L; Pieper C; Recknor C; Su G; Bucci-Rechtweg C; Magaziner J
    Calcif Tissue Int; 2011 Dec; 89(6):427-33. PubMed ID: 22038744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
    Vestergaard P; Schwartz F; Rejnmark L; Mosekilde L
    Osteoporos Int; 2011 Mar; 22(3):993-1001. PubMed ID: 21165600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.
    Lenart BA; Neviaser AS; Lyman S; Chang CC; Edobor-Osula F; Steele B; van der Meulen MC; Lorich DG; Lane JM
    Osteoporos Int; 2009 Aug; 20(8):1353-62. PubMed ID: 19066707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragility fractures of the hip and femur: incidence and patient characteristics.
    Nieves JW; Bilezikian JP; Lane JM; Einhorn TA; Wang Y; Steinbuch M; Cosman F
    Osteoporos Int; 2010 Mar; 21(3):399-408. PubMed ID: 19484169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
    Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
    J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage of failed osteosynthesis for an atypical subtrochanteric femoral fracture associated with long-term bisphosphonate treatment using a 95° angled blade plate.
    Kim SM; Rhyu KH; Lim SJ
    Bone Joint J; 2018 Nov; 100-B(11):1511-1517. PubMed ID: 30418051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
    Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
    N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.
    Abrahamsen B; Eiken P; Eastell R
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5258-65. PubMed ID: 20843943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate use and atypical fractures of the femoral shaft.
    Schilcher J; Michaëlsson K; Aspenberg P
    N Engl J Med; 2011 May; 364(18):1728-37. PubMed ID: 21542743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtrochanteric/femoral shaft versus hip fractures: incidences and identification of risk factors.
    Maravic M; Ostertag A; Cohen-Solal M
    J Bone Miner Res; 2012 Jan; 27(1):130-7. PubMed ID: 21956517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.